24 September 2024
Together with fantastic collaborators at the Amsterdam University Medical Center, in particular Jeffrey Umotoy and Steven de Taeye, we have generated a set of new single-domain antibodies against the challenging tetraspannin (4TM domains) CD9 described in this recent publication.
The researchers at the AUMC showed that these molecules prevented HIV-1 replication and syncytia formation. The molecules are available at QVQ.
